NPI: 1326104613 · HOUSTON, TX 77072 · Clinical Medical Laboratory · NPI assigned 12/29/2006
Authorized official TIMMERMAN, LEAH controls 20+ related entities in our dataset. Read more
| Authorized Official | TIMMERMAN, LEAH (SR. VICE PRESIDENT) |
| Parent Organization | QUEST DIAGNOSTICS INCORPORATED |
| NPI Enumeration Date | 12/29/2006 |
Other providers sharing the same authorized official: TIMMERMAN, LEAH
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 505,749 | $1.61M |
| 2019 | 485,450 | $1.73M |
| 2020 | 424,639 | $1.57M |
| 2021 | 448,216 | $1.83M |
| 2022 | 352,105 | $807K |
| 2023 | 270,887 | $709K |
| 2024 | 206,818 | $504K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 45,549 | 38,549 | $741K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 45,083 | 38,148 | $731K |
| 80050 | General health panel | 42,168 | 36,570 | $660K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 10,320 | 9,238 | $487K |
| 80061 | Lipid panel | 186,420 | 175,422 | $438K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 40,337 | 34,531 | $372K |
| 80053 | Comprehensive metabolic panel | 230,141 | 213,844 | $316K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 14,298 | 9,455 | $314K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 67,258 | 61,106 | $308K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 19,363 | 16,383 | $298K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 201,458 | 184,606 | $219K |
| 84443 | Thyroid stimulating hormone (TSH) | 120,172 | 114,598 | $203K |
| 83036 | Hemoglobin; glycosylated (A1C) | 149,472 | 139,077 | $201K |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 14,102 | 11,952 | $156K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 71,854 | 63,669 | $138K |
| 86480 | 7,159 | 6,369 | $125K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 6,558 | 5,658 | $124K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 8,833 | 7,020 | $118K |
| 86803 | 24,540 | 22,073 | $116K | |
| 80074 | 10,324 | 8,148 | $112K | |
| 86003 | 2,725 | 1,563 | $110K | |
| 87088 | 57,925 | 51,948 | $103K | |
| 80081 | 2,569 | 2,442 | $98K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 7,027 | 6,222 | $92K |
| 82607 | 27,333 | 25,252 | $69K | |
| 84439 | 42,926 | 40,346 | $65K | |
| 87522 | Neg quan hep c or qual rna | 4,122 | 3,540 | $63K |
| 82728 | 24,930 | 23,371 | $60K | |
| 84153 | 18,029 | 16,667 | $58K | |
| 87070 | 14,272 | 12,637 | $50K | |
| 86769 | 2,470 | 2,251 | $47K | |
| 86592 | 28,478 | 24,647 | $46K | |
| 87186 | 30,012 | 25,498 | $45K | |
| 87340 | 13,280 | 12,181 | $43K | |
| 87077 | 29,039 | 24,805 | $43K | |
| 85027 | 34,893 | 32,185 | $42K | |
| 82746 | 16,494 | 15,202 | $41K | |
| 83970 | 14,426 | 14,005 | $41K | |
| 86696 | 3,989 | 3,547 | $40K | |
| 83013 | 2,719 | 2,639 | $37K | |
| 83655 | 13,556 | 12,381 | $35K | |
| 84481 | 16,011 | 15,128 | $35K | |
| 83550 | 23,295 | 21,911 | $34K | |
| 87799 | 2,814 | 1,872 | $32K | |
| 84702 | 4,797 | 3,582 | $32K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 29,874 | 26,815 | $31K |
| 82570 | 51,620 | 48,879 | $30K | |
| 81513 | 1,637 | 1,556 | $29K | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | 2,215 | 2,072 | $29K |
| 84403 | 5,609 | 5,369 | $29K | |
| 87081 | 8,311 | 7,468 | $28K | |
| 83540 | 27,049 | 25,454 | $27K | |
| 86695 | 3,875 | 3,432 | $26K | |
| 82043 | 38,767 | 37,271 | $25K | |
| 83880 | 7,344 | 6,956 | $24K | |
| 83001 | 3,542 | 3,134 | $23K | |
| 86038 | 6,724 | 6,061 | $22K | |
| 81001 | 51,528 | 48,016 | $22K | |
| 86706 | 6,498 | 5,854 | $21K | |
| 82105 | 3,679 | 3,369 | $21K | |
| 84436 | 18,314 | 17,236 | $20K | |
| 36415 | Collection of venous blood by venipuncture | 235,959 | 215,523 | $20K |
| 86780 | 2,741 | 2,645 | $20K | |
| 82652 | 5,077 | 4,926 | $20K | |
| 84146 | 3,261 | 2,925 | $20K | |
| 82670 | 2,450 | 2,221 | $19K | |
| 86704 | 5,628 | 5,162 | $19K | |
| 86708 | 5,107 | 4,624 | $19K | |
| 83735 | 25,035 | 22,426 | $18K | |
| 82784 | 4,645 | 4,249 | $18K | |
| 80348 | 2,038 | 730 | $16K | |
| 83002 | 2,312 | 2,021 | $15K | |
| 87147 | 8,807 | 7,893 | $15K | |
| 80354 | 2,051 | 626 | $15K | |
| 82950 | 6,471 | 5,765 | $15K | |
| 86140 | 19,146 | 16,700 | $15K | |
| 84480 | 8,589 | 8,053 | $15K | |
| 82785 | 1,746 | 1,420 | $13K | |
| 82274 | 2,909 | 2,600 | $13K | |
| 80055 | 1,976 | 1,472 | $13K | |
| 85652 | 24,475 | 21,812 | $12K | |
| 86762 | 1,531 | 1,421 | $12K | |
| 87536 | 391 | 381 | $12K | |
| 84479 | 10,619 | 9,967 | $12K | |
| 80076 | 6,658 | 6,141 | $12K | |
| 83021 | 1,161 | 939 | $12K | |
| 84550 | 21,472 | 20,536 | $12K | |
| 87480 | 1,133 | 1,047 | $11K | |
| 87510 | 1,133 | 1,047 | $11K | |
| 80361 | 1,350 | 598 | $10K | |
| 85660 | 3,880 | 2,878 | $10K | |
| 86376 | 2,222 | 1,988 | $9K | |
| 85610 | 17,386 | 13,446 | $9K | |
| 87660 | 1,133 | 1,047 | $9K | |
| 82248 | 11,148 | 10,388 | $9K | |
| 80164 | 4,860 | 4,558 | $9K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 281 | 254 | $9K |
| 80346 | 1,005 | 435 | $9K | |
| 87512 | 621 | 543 | $8K | |
| 82550 | 8,655 | 7,931 | $8K | |
| 80349 | 1,088 | 436 | $8K | |
| 81003 | 23,660 | 22,116 | $8K | |
| 82951 | 1,256 | 1,131 | $8K | |
| 86235 | 1,103 | 1,073 | $8K | |
| 84144 | 939 | 748 | $8K | |
| 86431 | 6,428 | 6,041 | $7K | |
| 88142 | 778 | 623 | $7K | |
| 84156 | 16,640 | 15,378 | $7K | |
| 80362 | 853 | 308 | $7K | |
| 83525 | 2,071 | 1,892 | $7K | |
| 87075 | 2,863 | 2,606 | $6K | |
| 83690 | 4,722 | 4,388 | $6K | |
| 84703 | 1,741 | 1,546 | $6K | |
| 80365 | 728 | 411 | $6K | |
| 86317 | 1,447 | 1,347 | $6K | |
| 88141 | 649 | 625 | $6K | |
| 86160 | 2,099 | 2,050 | $6K | |
| 84100 | 17,075 | 15,314 | $6K | |
| 86850 | 1,243 | 1,183 | $5K | |
| 84402 | 1,137 | 1,121 | $5K | |
| 80069 | 6,979 | 6,676 | $5K | |
| 85730 | 5,630 | 5,097 | $5K | |
| 87209 | 642 | 537 | $5K | |
| 83520 | 2,031 | 1,389 | $5K | |
| 83516 | 1,349 | 1,173 | $5K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 133 | 128 | $4K |
| 83615 | 4,489 | 3,916 | $4K | |
| 82150 | 3,475 | 3,227 | $4K | |
| 82378 | 2,106 | 1,913 | $4K | |
| 87205 | 3,699 | 3,337 | $3K | |
| 84460 | 3,194 | 3,004 | $3K | |
| 87427 | 571 | 492 | $3K | |
| 86039 | 1,139 | 1,081 | $3K | |
| 85018 | 3,446 | 3,234 | $3K | |
| 82677 | 242 | 174 | $3K | |
| 87045 | 665 | 571 | $3K | |
| 85045 | 2,980 | 2,796 | $3K | |
| 80324 | 326 | 210 | $2K | |
| 87177 | 642 | 537 | $2K | |
| 86360 | 123 | 118 | $2K | |
| 84450 | 2,738 | 2,545 | $2K | |
| 82565 | 3,742 | 3,394 | $2K | |
| 86200 | 1,230 | 1,146 | $2K | |
| 87046 | 538 | 459 | $2K | |
| 86901 | 1,345 | 1,264 | $2K | |
| 86900 | 1,341 | 1,263 | $2K | |
| 82533 | 764 | 674 | $2K | |
| 82977 | 2,029 | 1,877 | $2K | |
| 86787 | 362 | 294 | $2K | |
| 83020 | 314 | 312 | $2K | |
| 84132 | 1,633 | 1,536 | $2K | |
| 87338 | 335 | 304 | $2K | |
| 82947 | 2,363 | 2,201 | $2K | |
| 87497 | 800 | 629 | $2K | |
| 82952 | 978 | 875 | $2K | |
| 86300 | 422 | 342 | $2K | |
| 86336 | 242 | 174 | $2K | |
| 85014 | 2,540 | 2,399 | $2K | |
| 99199 | Unlisted special service, procedure or report | 129 | 108 | $2K |
| 83698 | 658 | 612 | $2K | |
| 86765 | 204 | 171 | $1K | |
| 80178 | 1,712 | 1,580 | $1K | |
| 84165 | 1,454 | 1,413 | $1K | |
| 86593 | 799 | 690 | $1K | |
| 82310 | 2,354 | 2,258 | $1K | |
| 80197 | 2,221 | 1,673 | $1K | |
| 86735 | 187 | 156 | $1K | |
| 84681 | 457 | 444 | $1K | |
| 86800 | 495 | 442 | $1K | |
| 80177 | 1,801 | 1,720 | $1K | |
| 82627 | 191 | 174 | $1K | |
| 86225 | 831 | 778 | $1K | |
| 82330 | 1,205 | 999 | $1K | |
| 87449 | 316 | 261 | $1K | |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed | 204 | 200 | $1K |
| 86008 | 27 | 15 | $991.59 | |
| 80359 | 213 | 86 | $959.76 | |
| 81015 | 1,454 | 1,295 | $957.46 | |
| 81025 | 232 | 219 | $952.02 | |
| 86141 | 996 | 929 | $928.72 | |
| 82247 | 1,571 | 1,479 | $901.59 | |
| 86255 | 986 | 812 | $887.40 | |
| 80335 | 171 | 70 | $851.40 | |
| 84520 | 2,552 | 2,281 | $834.51 | |
| 87902 | 24 | 24 | $806.60 | |
| 80320 | 86 | 83 | $794.64 | |
| 83090 | 308 | 273 | $793.65 | |
| 84154 | 492 | 461 | $768.20 | |
| 80185 | 710 | 671 | $746.60 | |
| 80373 | 114 | 97 | $745.62 | |
| 84134 | 459 | 416 | $716.34 | |
| 80051 | 691 | 621 | $703.05 | |
| 80156 | 529 | 516 | $697.71 | |
| 80321 | 121 | 67 | $689.56 | |
| 80358 | 103 | 68 | $648.66 | |
| 87254 | 85 | 37 | $637.10 | |
| 86334 | 628 | 606 | $634.50 | |
| 80369 | 99 | 65 | $618.28 | |
| 84425 | 372 | 367 | $600.94 | |
| 80353 | 66 | 46 | $590.55 | |
| 85379 | 238 | 226 | $547.67 | |
| 80372 | 89 | 77 | $540.94 | |
| 83014 | 366 | 359 | $505.92 | |
| 84155 | 1,824 | 1,768 | $480.42 | |
| 84484 | 98 | 83 | $460.16 | |
| 85041 | 271 | 227 | $453.78 | |
| 82040 | 1,735 | 1,663 | $451.28 | |
| 82140 | 796 | 704 | $448.16 | |
| 80368 | 61 | 42 | $443.76 | |
| 87324 | 108 | 104 | $431.59 | |
| 84478 | 179 | 146 | $370.22 | |
| 82610 | 337 | 297 | $349.16 | |
| 83992 | 35 | 30 | $339.78 | |
| 84075 | 1,281 | 1,243 | $325.57 | |
| 83704 | 712 | 698 | $319.06 | |
| 80367 | 49 | 26 | $263.16 | |
| 86146 | 21 | 12 | $257.32 | |
| 80356 | 21 | 19 | $248.54 | |
| 82172 | 1,098 | 1,082 | $233.07 | |
| 99001 | 66 | 60 | $232.32 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 17 | 17 | $225.60 |
| 84270 | 70 | 66 | $213.37 | |
| 83721 | 309 | 302 | $194.34 | |
| 86812 | 12 | 12 | $168.24 | |
| 87329 | 25 | 25 | $159.12 | |
| 83883 | 460 | 287 | $158.00 | |
| 83695 | 811 | 799 | $140.25 | |
| 80345 | 18 | 13 | $114.43 | |
| 87101 | 32 | 28 | $108.77 | |
| 80366 | 22 | 12 | $99.33 | |
| 80360 | 24 | 13 | $99.33 | |
| 86304 | 39 | 38 | $75.15 | |
| 86301 | 58 | 51 | $75.15 | |
| 80355 | 22 | 12 | $70.98 | |
| 86021 | 62 | 61 | $54.35 | |
| 80175 | 72 | 64 | $47.85 | |
| 82465 | 56 | 56 | $44.10 | |
| 84466 | 15 | 12 | $39.93 | |
| 84295 | 219 | 199 | $39.78 | |
| 83519 | 21 | 12 | $33.84 | |
| 85007 | 53 | 50 | $32.24 | |
| 81511 | 100 | 89 | $30.70 | |
| 82525 | 12 | 12 | $26.88 | |
| 80158 | 240 | 209 | $26.08 | |
| G0145 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision | 1,069 | 1,055 | $25.89 |
| 86364 | 174 | 173 | $18.44 | |
| 82435 | 55 | 52 | $18.07 | |
| 83789 | 13 | 12 | $16.99 | |
| 84432 | 14 | 14 | $11.60 | |
| 85048 | 13 | 12 | $11.22 | |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | 5,930 | 5,896 | $3.39 |
| 83718 | 31 | 31 | $0.00 | |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed | 32 | 26 | $0.00 |
| 84166 | 41 | 41 | $0.00 | |
| 83876 | 17 | 17 | $0.00 | |
| 86015 | 13 | 13 | $0.00 | |
| 80235 | 12 | 12 | $0.00 | |
| 86036 | 12 | 12 | $0.00 | |
| 86709 | 12 | 12 | $0.00 | |
| 81596 | 54 | 53 | $0.00 | |
| G0306 | Complete cbc, automated (hgb, hct, rbc, wbc, without platelet count) and automated wbc differential count | 420 | 405 | $0.00 |
| G0328 | Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | 1,331 | 1,326 | $0.00 |
| G0472 | Hepatitis c antibody screening, for individual at high risk and other covered indication(s) | 555 | 554 | $0.00 |
| 83010 | 75 | 74 | $0.00 | |
| 80201 | 13 | 13 | $0.00 | |
| 80184 | 53 | 52 | $0.00 | |
| 87517 | 101 | 101 | $0.00 | |
| 82390 | 12 | 12 | $0.00 | |
| G0123 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision | 40 | 40 | $0.00 |
| 80183 | 12 | 12 | $0.00 | |
| 86381 | 14 | 14 | $0.00 |